Cortical amyloid PET burden

Biomarker1 paper1 finding

Humans1

Upstream

1

DTI-ALPS

downin humans1

1 study

DTI-ALPS decreases cortical amyloid PET burden in humans (β = -0.025, 95% HDI [-0.049, -0.001]).
Humans3 years
DTI-ALPS as a Biomarker of Small Vessel Disease Progression and Amyloid-β in Normal Aging: A 3-Year Longitudinal Study · Human brain mapping · 21 Sep 2026

Latest

1

Human Brain MappingHumans21 Sep

DTI-ALPS as a Biomarker of Small Vessel Disease Progression and Amyloid-β in Normal Aging: A 3-Year Longitudinal Study